The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins

Molecular Oncology

Volumn 6, Issue 3, 2012, Pages 323-332

  Weng, Alexander ^a   Thakur, Mayank ^a   Beceren Braun, Figen ^a   Bachran, Diana ^a   Bachran, Christopher ^b   Riese, Sebastian B ^a   Jenett Siems, Kristina ^c   Gilabert Oriol, Roger ^a   Melzig, Matthias F ^c   Fuchs, Hendrik ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cancer therapy; Saponin; Targeted toxin; Toxin efficacy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SA 1641; SAPONIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG PURIFICATION; DRUG TARGETING; GENETIC TRANSFECTION; GYPSOPHILA PANICULATA; HUMAN; HUMAN CELL; MEDICINAL PLANT; MEMBRANE PERMEABILITY; PRIORITY JOURNAL;

GYPSOPHILA PANICULATA;

EID: 84861458204     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.01.004     Document Type: Article

References (23)

1. Bachran C., Durkop H., Sutherland M., Bachran D., Muller C., Weng A., Melzig M.F., Fuchs H. Inhibition of tumor growth by targeted toxins in mice is dramatically improved by saponinum album in a synergistic way. J. Immunother. 2009, 32:713-725.
2. Bachran C., Heisler I., Fuchs H., Sutherland M. Influence of protein transduction domains on target-specific chimeric proteins. Biochem. Biophys. Res. Commun. 2005, 337:602-609.
3. Bachran C., Sutherland M., Bachran D., Fuchs H. Quantification of diphtheria toxin mediated ADP-ribosylation in a solid-phase assay. Clin. Chem. 2007, 53:1676-1683.
4. Bachran D., Schneider S., Bachran C., Urban R., Weng A., Melzig M.F., Hoffmann C., Kaufmann A.M., Fuchs H. Epidermal growth factor receptor expression affects the efficacy of the combined application of saponin and a targeted toxin on human cervical carcinoma cells. Int. J. Cancer 2010, 127:1453-1461.
5. Caron N.J., Quenneville S.P., Tremblay J.P. Endosome disruption enhances the functional nuclear delivery of tat-fusion proteins. Biochem. Biophys. Res. Commun. 2004, 319:12-20.
6. Collier R.J., Kandel J. Structure and activity of diphtheria toxin. I. Thiol-dependent dissociation of a fraction of toxin into enzymically active and inactive fragments. J. Biol. Chem. 1971, 246:1496-1503.
7. Fermani S., Tosi G., Farini V., Polito L., Falini G., Ripamonti A., Barbieri L., Chambery A., Bolognesi A. Structure/function studies on two type 1 ribosome inactivating proteins: bouganin and lychnin. J. Struct. Biol. 2009, 168:278-287.
8. Frankel A.E., Powell B.L., Lilly M.B. Diphtheria toxin conjugate therapy of cancer. Cancer Chemother. Biol. Response Modif. 2002, 20:301-313.
9. Fuchs H., Bachran C. Targeted tumor therapies at a glance. Curr. Drug Targets 2009, 10:89-93.
10. Heisler I., Keller J., Tauber R., Sutherland M., Fuchs H. A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins. Int. J. Cancer 2003, 103:277-282.
11. Hsuchen C.C., Feingold D.S. Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes). Antimicrob. Agents Chemother. 1973, 4:309-315.
12. Huotari J., Helenius A. Endosome maturation. EMBO J. 2011, 30:3481-3500.
13. Kreitman R.J. Immunotoxins for targeted cancer therapy. AAPS J. 2006, 8:E532-E551.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
15. Pirie C.M., Hackel B.J., Rosenblum M.G., Wittrup K.D. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties. J. Biol. Chem. 2010, 286:4165-4172.
16. Sigismund S., Argenzio E., Tosoni D., Cavallaro E., Polo S., Di Fiore P.P. Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev. Cell 2008, 15:209-219.
17. Silverstein A.M. The collected papers of Paul Ehrlich: why was volume 4 never published?. Bull. Hist. Med. 2002, 76:335-339.
18. Stirpe F., Battelli M.G. Ribosome-inactivating proteins: progress and problems. Cell Mol. Life Sci. 2006, 63:1850-1866.
19. Varkouhi A.K., Scholte M., Storm G., Haisma H.J. Endosomal escape pathways for delivery of biologicals. J. Control Release 2010.
20. Weng A., Bachran D., Gorick C., Bachran C., Fuchs H., Melzig M.F. A simple method for isolation of Gypsophila saponins for the combined application of targeted toxins and saponins in tumor therapy. Planta Med. 2009, 75:1421-1422.
21. Weng A., Gorick C., Melzig M.F. Enhancement of toxicity of saporin-based toxins by Gypsophila saponins-kinetic of the saponin. Exp. Biol. Med. (Maywood) 2009, 234:961-966.
22. Weng A., Jenett-Siems K., Schmieder P., Bachran D., Bachran C., Gorick C., Thakur M., Fuchs H., Melzig M.F. A convenient method for saponin isolation in tumour therapy. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2010, 878:713-718.
23. Woo J.H., Lee Y.J., Neville D.M., Frankel A.E. Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials. Methods Mol. Biol. 2010, 651:157-175.